Consider These Two Factors When Choosing The Right CDMO For Developing Injectable Medicines

By Anna Benefiel, Singota Solutions

Singota Solutions is a U.S.-based Contract Development and Manufacturing Organization (CDMO) located in Bloomington, Indiana, specializing in formulation development and aseptic fill/finish services for injectable medicines. With over 20 years of proven experience, Singota supports young biopharmaceutical companies by offering a comprehensive, end-to-end suite of services, including analytical development, process optimization, cGMP manufacturing, supply chain support, and packaging.

Two key factors set Singota apart as a top-tier CDMO partner: technical expertise and near-term availability. Their team of seasoned scientists and formulation experts helps clients navigate complex drug development stages—from preclinical formulation to process development—while proactively managing risk and ensuring regulatory compliance. Singota’s robust scientific capabilities allow for effective decision-making, especially during the critical transition from drug substance to drug product.

What makes Singota unique is its agile operational model. Unlike larger CDMOs that often impose long wait times, Singota offers accelerated timelines, with the ability to reschedule or accommodate urgent projects within weeks. Their flexibility, rooted in being a privately-held and tightly-managed organization, means clients benefit from quick responses and consistent support.

Singota also distinguishes itself with state-of-the-art robotic filling technology, ideal for small-batch injectable needs. Their collaborative culture, reliable regulatory track record, and commitment to getting things right the first time have earned them a reputation as both a problem-solver and a proactive partner. Whether you're launching a new product or need urgent fill/finish support, Singota Solutions offers a smart, responsive alternative in the injectable CDMO landscape.